Protara Therapeutics
Price & Volume
Stats
See more52W Range | $1.59-$6.87 |
Market Cap | $135.7M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.17 |
News
See moreYahoo Finance • 7 days ago
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
Yahoo Finance • 14 days ago
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
Yahoo Finance • 19 days ago
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
Yahoo Finance • 2 months ago
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
About
CEO | Mr. Jesse Shefferman |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
